Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Buscarinu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Scientific Reports|April 8, 2017
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsC Eleuteri, S Olla, C Veroni, et al.
Cytokine & Growth Factor Reviews|December 4, 2014
IFN-β and multiple sclerosis: from etiology to therapy and backV Annibali, R Mechelli, S Romano, et al.
Neuroscience and Biobehavioral Reviews|January 25, 2020
Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studiesM C Buscarinu, A Fornasiero, M Ferraldeschi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 10, 2017
Intestinal Permeability in Relapsing-Remitting Multiple SclerosisM C Buscarinu, S Romano, R Mechelli, et al.
Journal of the Neurological Sciences|April 10, 2021
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgiaD Ferraro, P Annovazzi, R Lanzillo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2020
Informing MS patients on treatment options: a consensus on the process of consent takingC Tortorella, C Solaro, P Annovazzi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Scientific Reports|April 8, 2017
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsC Eleuteri, S Olla, C Veroni, et al.
Cytokine & Growth Factor Reviews|December 4, 2014
IFN-β and multiple sclerosis: from etiology to therapy and backV Annibali, R Mechelli, S Romano, et al.
Neuroscience and Biobehavioral Reviews|January 25, 2020
Disentangling the molecular mechanisms of multiple sclerosis: The contribution of twin studiesM C Buscarinu, A Fornasiero, M Ferraldeschi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 10, 2017
Intestinal Permeability in Relapsing-Remitting Multiple SclerosisM C Buscarinu, S Romano, R Mechelli, et al.
Journal of the Neurological Sciences|April 10, 2021
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgiaD Ferraro, P Annovazzi, R Lanzillo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 3, 2020
Informing MS patients on treatment options: a consensus on the process of consent takingC Tortorella, C Solaro, P Annovazzi, et al.
Pageof 1